BLIS Production in the Genus Streptococcus

  • J. R. Tagg
Part of the NATO ASI Series book series (volume 65)


Streptococci have been found to comprise a substantial proportion of the indigenous microbiota and of the bacterial pathogens of humans and other animals.For 21 years now, the principal research focus of my laboratory has been the investigation of the production by streptococci of bacteriocin-like inhibitory substances (BLIS) (Tagg, Dajani & Wannamaker, 1976).


Test Strain Mutans Streptococcus Indicator Strain Streptococcal Species Haemolytic Streptococcus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barnham M, Cole G, Efstratiou A, Tagg JR, Skjold SA (1987) Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidem Inf 98:171–182CrossRefGoogle Scholar
  2. Crooks M, James SM, Tagg JR (1987) Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zbl Bakt Hyg I Abt Orig A 263:541–547Google Scholar
  3. Jack RW, Tagg JR (1991) Isolation and partial structure of streptococcin A-FF22. In: Jung G, Sahl H-G (eds) Lantibiotics. (in press)Google Scholar
  4. James SM, Tagg JR (1986) The typing of enterococcus strains according to their production of bacteriocin-like inhibitory activity. Proc Univ Otago Med Sch 64:65–66Google Scholar
  5. Ragland NL, Tagg JR (1990) Applications of bacteriocin-like inhibitory substance (BLIS) typing in a longitudinal study of oral carriage of ß-haemolytic streptococci by a group of Dunedin schoolchildren. Zbl Bakt Hyg I Abt Orig A 274:100–108Google Scholar
  6. Schofield CR, Tagg JR (1983) Bacteriocin-like activity of group B and group C streptococci of human and animal origin. J Hyg 90:7–18CrossRefGoogle Scholar
  7. Tagg JR (1985) An inhibitor ‘fingerprinting’ scheme applicable to Lancefield group E streptococci. Canad J Microbiol 31:1056–1057CrossRefGoogle Scholar
  8. Tagg JR, Bannister LV (1979) “Fingerprinting” ß-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol 12:397–411PubMedCrossRefGoogle Scholar
  9. Tagg JR, Van de Rijn I (1991) An inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes BLIS. J Clin Microbiol 29: 848–849PubMedGoogle Scholar
  10. Tagg JR, VuglerLG (1986) An inhibitor typing scheme for Streptococcus uberis. J Dairy Res 53:451–456PubMedCrossRefGoogle Scholar
  11. Tagg JR, Wannamaker LW (1978) Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother 14:31–39PubMedGoogle Scholar
  12. Tagg JR, Wong HK (1983) Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol 16:409–415PubMedCrossRefGoogle Scholar
  13. Tagg JR, Dajani AS, Wannamaker LW (1976) Bacteriocins of gram-positive bacteria. Bacteriol Rev 40: 722–756PubMedGoogle Scholar
  14. Tagg JR, Pybus V, Phillips LV, Fiddes TM (1983) Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol 28:911–915PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • J. R. Tagg
    • 1
  1. 1.Department of MicrobiologyUniversity of OtagoDunedinNew Zealand

Personalised recommendations